Enteral Feeding Devices Market - Global Forecasts to 2030
商品番号 : SMB-8468
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年5月 |
| ページ数 | 302 |
| 図表数 | 335 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 4,950 |
| 種別 | 英文調査報告書 |
- 本レポートは、経腸栄養装置市場を製品、年齢層、用途、エンドユーザー、地域別に分析しています。
- 本レポートでは、市場の成長に影響を与える推進要因、制約要因、機会、課題を分析しています。
- 本レポートでは、市場における機会と課題をステークホルダーの観点から評価し、市場リーダーの競争環境の詳細を提供しています。
- 本レポートでは、ミクロ市場の成長傾向、見通し、そして市場全体への貢献について調査しています。
- 本レポートでは、5つの主要地域における市場セグメントの収益予測を行っています。
The global market for enteral feeding devices is projected to reach USD 3,994.2 million by 2030, from USD 2,965.1 million in 2025. This expansion is largely driven by advancements in medical technology, which have made enteral feeding systems safer, more effective, and easier for caregivers and family members to manage. Rigorous specifications from healthcare authorities ensure that these systems meet high standards of safety and efficiency. Other factors contributing to market growth include competition within the industry, demographic shifts, economic factors, globalization, patient-centered design, digital integration, and sustainability considerations.
経腸栄養装置の世界市場は、2025年の29億6,510万米ドルから、2030年には39億9,420万米ドルに達すると予測されています。この拡大は、医療技術の進歩によって経腸栄養システムがより安全で効果的になり、介護者や家族にとって管理が容易になったことに大きく起因しています。医療当局による厳格な仕様設定により、これらのシステムは高い安全性と効率性基準を満たしていることが保証されています。市場の成長に貢献するその他の要因としては、業界内の競争、人口動態の変化、経済要因、グローバル化、患者中心の設計、デジタル統合、持続可能性への配慮などが挙げられます。
“Enteral feeding tubes to be largest segment during forecast period”
The enteral feeding tubes segment is projected to hold the largest share of the enteral feeding devices market between 2025 and 2030. Key factors driving this trend include the increased prevalence of chronic illnesses, the rise in geriatric population, rapid advancements in technology, a surge in home health care, pediatric applications, heightened awareness of nutritional management, compliance with regulations, and increased health care spending. Manufacturers will need to innovate flexibly to meet diverse patient needs while ensuring safety and usability in various clinical settings, influenced by the global evolution of these factors.
“Oncology to surpass other applications during forecast period”
In 2024, the oncology segment accounted for the largest share of the enteral feeding devices market, and this trend is expected to continue during the forecast period. The factors influencing enteral feeding practices in oncology include nutritional support for the cancer treatment patient, enhanced recovery after surgery protocol, management of cancer-related malnutrition, technological advances, individualized nutritional planning, integration of enteral feeding with palliative care, economic issues, regulatory support, patient education, and other related ongoing research and development. These factors facilitate the effective utilization of enteral feeding to enhance the patient’s quality of life and outcomes pertaining to a cancer diagnosis.
“Hospitals & surgical centers segment to be prevalent during forecast period”
Hospitals & surgical centers are expected to be the largest segment in the enteral feeding devices market during the forecast period. The increasing use of enteral feeding in these facilities is primarily due to its positive impact on patient outcomes and the resulting cost savings in healthcare. Other contributing factors include compliance with regulations, advancements in technology, enhancements in patient safety and comfort, increased awareness and education about enteral feeding, integration with electronic health records (EHR), government initiatives, patient-centered care models, and collaboration among healthcare professionals. As these factors evolve, enteral feeding will continue to play a crucial role in patient care in hospitals and surgical centers.
“Asia Pacific to register significant growth during forecast period”
The Asia Pacific region, comprising Japan, India, China, South Korea, Australia, and the Rest of Asia Pacific, is anticipated to experience substantial growth during the forecast period. The region has experienced a notable acceleration in the market growth rate for enteral feeding devices. Contributing factors include demographic changes, economic growth, increased affordability, advancements in technology, regulatory frameworks, improved healthcare awareness, the expansion of healthcare services, enhanced trade and market access, and various government initiatives. Together, these factors create a highly dynamic market that fosters innovation and growth opportunities for both local and international companies.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1 – 40%, Tier 2 – 30%, and Tier 3 – 30%
- By Designation: C-level — 27%, Director-level – 18%, and Others – 55%
- By Region: North America – 50%, Europe – 20%, Asia Pacific – 15%, Latin America – 10%, and Middle East & Africa – 5%
Prominent players in this market are Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others.
Research Coverage
- The report studies the enteral feeding devices market based on product, age group, application, end user, and region.
- The report analyzes drivers, restraints, opportunities, and challenges affecting the market growth.
- The report evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders.
- The report studies micro markets with respect to their growth trends, prospects, and contributions to the overall market.
- The report forecasts the revenue of market segments with respect to five major regions.
Key Benefits of Buying this Report:
The report aims to assist new entrants, smaller firms, and market leaders in evaluating investment opportunities within the enteral feeding devices market. It offers a thorough analysis of comprehensive data, enabling informed investment decisions and effective risk assessment. By providing detailed market segmentation that includes end-user categories and regional considerations, the report offers tailored insights for precise targeting of specific segments. Additionally, it delivers an extensive evaluation of key trends, challenges, growth factors, and opportunities, empowering strategic decision-making with a clear understanding.
The report provides insights on the following pointers:
- Market Dynamics: Analysis of key drivers, restraints, opportunities, and challenges influencing the growth of the enteral feeding devices market
- Product Development/Innovation: Detailed insights on upcoming technologies, R&D activities, and product & service launches in the enteral feeding devices market
- Market Development: Comprehensive information about lucrative markets
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the enteral feeding devices market
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and service offerings of leading players like Fresenius SE & Co. KGAA. (Germany), Cardinal Health, Inc. (US), Avanos Medical, Inc. (US), Becton, Dickinson and Company (US), B. Braun Melsungen AG (Germany), CONMED Corporation (US), Cook Medical (US), Boston Scientific Corporation (US), and Baxter International Inc. (US), among others
Table of Contents
1 INTRODUCTION 27
1.1 STUDY OBJECTIVES 27
1.2 MARKET DEFINITION 27
1.3 STUDY SCOPE 28
1.3.1 MARKETS COVERED AND REGIONAL SCOPE 28
1.3.2 INCLUSIONS AND EXCLUSIONS 29
1.3.3 YEARS CONSIDERED 29
1.4 CURRENCY CONSIDERED 30
1.5 STAKEHOLDERS 30
1.6 SUMMARY OF CHANGES 31
2 RESEARCH METHODOLOGY 32
2.1 RESEARCH DATA 32
2.1.1 SECONDARY RESEARCH 33
2.1.1.1 List of secondary sources 33
2.1.1.2 Key data from secondary sources 34
2.1.1.3 Objectives of secondary research 34
2.1.2 PRIMARY RESEARCH 35
2.1.2.1 List of primary sources (demand and supply sides) 35
2.1.2.2 Supply- and demand-side participants 35
2.1.2.3 Breakdown of primary interviews (supply side) 36
2.1.2.4 Breakdown of primary interviews (demand side) 36
2.1.2.5 Objectives of primary research 36
2.2 MARKET SIZE ESTIMATION 37
2.2.1 BOTTOM-UP APPROACH 38
2.2.1.1 Approach 1: Company revenue estimation 39
2.2.1.2 Approach 2: Customer-based market estimation 39
2.2.1.3 Approach 3: Primary interviews 40
2.2.2 TOP-DOWN APPROACH 40
2.3 GROWTH FORECAST ASSUMPTIONS 42
2.4 DATA TRIANGULATION 44
2.5 RESEARCH ASSUMPTIONS 45
2.6 RESEARCH LIMITATIONS 45
2.7 RISK ASSESSMENT 45
3 EXECUTIVE SUMMARY 46
4 PREMIUM INSIGHTS 50
4.1 ATTRACTIVE OPPORTUNITIES FOR PLAYERS IN ENTERAL FEEDING DEVICES MARKET 50
4.2 ENTERAL FEEDING DEVICES MARKET, BY REGION 51
4.3 US ENTERAL FEEDING DEVICES MARKET, BY COUNTRY AND END USER 52
4.4 ENTERAL FEEDING DEVICES MARKET, BY COUNTRY 53
5 MARKET OVERVIEW 54
5.1 INTRODUCTION 54
5.2 MARKET DYNAMICS 54
5.2.1 DRIVERS 55
5.2.1.1 Benefits and cost-effectiveness of enteral nutrition 55
5.2.1.2 High incidence of preterm births and genetic disorders in pediatric and neonatal patients 55
5.2.1.3 Rapid growth in geriatric population and age-related chronic diseases 56
5.2.1.4 Increasing prevalence of dysphagia 58
5.2.2 RESTRAINTS 58
5.2.2.1 Complications associated with enteral feeding devices 58
5.2.2.2 Lack of awareness about feeding tubes 61
5.2.3 OPPORTUNITIES 61
5.2.3.1 High growth opportunities in emerging economies 61
5.2.3.2 Growing demand for enteral feeding in home care settings 62
5.2.4 CHALLENGES 62
5.2.4.1 Insufficient reimbursement policies in emerging economies 62
5.2.4.2 Shortage of endoscopy specialists 63
5.3 PORTER’S FIVE FORCES ANALYSIS 64
5.3.1 THREAT OF NEW ENTRANTS 65
5.3.2 THREAT OF SUBSTITUTES 65
5.3.3 BARGAINING POWER OF SUPPLIERS 65
5.3.4 BARGAINING POWER OF BUYERS 65
5.3.5 INTENSITY OF COMPETITIVE RIVALRY 65
5.4 REGULATORY LANDSCAPE 66
5.4.1 REGULATORY ANALYSIS 66
5.4.2 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
5.5 REIMBURSEMENT SCENARIO 69
5.6 ECOSYSTEM ANALYSIS 69
5.7 INVESTMENT AND FUNDING SCENARIO 70
5.8 TECHNOLOGY ANALYSIS 71
5.8.1 KEY TECHNOLOGIES 71
5.8.1.1 Flow generation mechanisms 71
5.8.1.2 Flow control technologies 72
5.8.2 COMPLEMENTARY TECHNOLOGIES 72
5.8.2.1 Smart feeding pumps 72
5.8.2.2 Feeding tube replacement technologies 72
5.8.3 ADJACENT TECHNOLOGIES 72
5.8.3.1 Patient monitoring systems 72
5.8.3.2 Digital connectivity 73
5.8.3.3 Nutrition supplements 73
5.9 VALUE CHAIN ANALYSIS 73
5.9.1 RESEARCH AND DEVELOPMENT 73
5.9.2 RAW MATERIAL PROCUREMENT AND PRODUCT MANUFACTURING 74
5.9.3 DISTRIBUTION, MARKETING AND SALES, AND AFTER-SALES SERVICES 74
5.10 SUPPLY CHAIN ANALYSIS 75
5.10.1 PROMINENT COMPANIES 75
5.10.2 SMALL AND MEDIUM-SIZED ENTERPRISES 75
5.10.3 END USERS 76
5.11 PRICING ANALYSIS 76
5.11.1 AVERAGE SELLING PRICE TREND, BY PRODUCT 77
5.11.2 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES OFFERED BY KEY PLAYERS 79
5.11.3 AVERAGE SELLING PRICE TREND, BY REGION 83
5.12 PATENT ANALYSIS 85
5.13 TRADE ANALYSIS 87
5.13.1 IMPORT SCENARIO (HS CODE 901839) 87
5.13.2 EXPORT SCENARIO (HS CODE 901839) 88
5.14 KEY CONFERENCES AND EVENTS, 2025–2026 89
5.15 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90
5.16 KEY STAKEHOLDERS AND BUYING CRITERIA 91
5.16.1 KEY STAKEHOLDERS IN BUYING PROCESS 91
5.16.2 BUYING CRITERIA 92
5.17 UNMET NEEDS AND KEY PAIN POINTS 93
5.18 IMPACT OF AI ON ENTERAL FEEDING DEVICES MARKET 94
6 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT 95
6.1 INTRODUCTION 96
6.2 ENTERAL FEEDING TUBES 96
6.2.1 NASAL FEEDING TUBES 100
6.2.1.1 Need for short-term feeding with minimal tube replacement to drive market 100
6.2.2 ORAL FEEDING TUBES 103
6.2.2.1 Extensive use in feeding preterm babies to drive market 103
6.2.3 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) 106
6.2.3.1 Escalating demand for PEG and PRG tubes to drive market 106
6.2.4 JEJUNOSTOMY TUBES (J-TUBES) 110
6.2.4.1 Trend of minimally invasive procedures to drive market 110
6.2.5 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) 113
6.2.5.1 Reduced tube dislodgment and user-friendly feeding to drive market 113
6.3 ENTERAL FEEDING PUMPS 116
6.3.1 RAPID GROWTH IN HOME HEALTHCARE TO DRIVE MARKET 116
6.4 ENTERAL SYRINGE PUMPS 120
6.4.1 RELIANCE ON TUBE FEEDING TO DRIVE MARKET 120
6.5 CONSUMABLES & ACCESSORIES 123
6.5.1 SYRINGES 127
6.5.1.1 Technological improvements to drive market 127
6.5.2 EXTENSION SETS 129
6.5.2.1 Safe and flexible delivery of nutrition, fluids, and medications to drive market 129
6.5.3 ADAPTERS 132
6.5.3.1 Focus on biocompatible materials and minimally invasive designs to drive market 132
6.5.4 NUTRITION STRAWS 134
6.5.4.1 Emergence of home enteral nutrition programs to drive market 134
7 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP 137
7.1 INTRODUCTION 138
7.2 NEONATAL PATIENTS 138
7.2.1 RISE IN PRETERM BIRTHS TO DRIVE MARKET 138
7.3 PEDIATRIC PATIENTS 139
7.3.1 HEIGHTENED CONCERNS OF MALNUTRITION TO DRIVE MARKET 139
7.4 ADULT PATIENTS 140
7.4.1 HIGH BURDEN OF CHRONIC DISEASES TO DRIVE MARKET 140
7.5 GERIATRIC PATIENTS 141
7.5.1 DEMOGRAPHIC TRENDS AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET 141
8 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION 143
8.1 INTRODUCTION 144
8.2 ONCOLOGY 144
8.2.1 INCREASED PREVALENCE OF CANCER TO DRIVE MARKET 144
8.3 GASTROINTESTINAL DISORDERS 146
8.3.1 RISE OF IRRITABLE BOWEL SYNDROME AND GASTROESOPHAGEAL REFLUX DISEASE TO DRIVE MARKET 146
8.4 NEUROLOGICAL DISORDERS 147
8.4.1 SURGE IN DEMAND FOR CLINICAL NUTRITION THERAPIES TO DRIVE MARKET 147
8.5 DIABETES 148
8.5.1 NEED FOR CONTROLLED ADMINISTRATION OF MEDICATIONS TO DRIVE MARKET 148
8.6 METABOLIC DISORDERS 150
8.6.1 GROWING INCIDENCE OF BURN INJURIES AND SEPSIS TO DRIVE MARKET 150
8.7 OTHER APPLICATIONS 151
9 ENTERAL FEEDING DEVICES MARKET, BY END USER 153
9.1 INTRODUCTION 154
9.2 HOSPITALS & SURGICAL CENTERS 154
9.2.1 RAPID ADOPTION OF ENTERAL FEEDING DEVICES IN INTENSIVE CARE UNITS TO DRIVE MARKET 154
9.3 HOME CARE 155
9.3.1 SUBSTANTIAL HOSPITALIZATION COSTS TO DRIVE MARKET 155
9.4 AMBULATORY CARE SETTINGS 156
9.4.1 ELEVATED DEMAND FOR SPECIALTY CARE TO DRIVE MARKET 156
9.5 OTHER END USERS 157
10 ENTERAL FEEDING DEVICES MARKET, BY REGION 159
10.1 INTRODUCTION 160
10.2 NORTH AMERICA 160
10.2.1 MACROECONOMIC OUTLOOK 161
10.2.2 US 164
10.2.2.1 Presence of major enteral feeding device providers to drive market 164
10.2.3 CANADA 166
10.2.3.1 Increasing incidence of chronic diseases such as diabetes and cancer to drive market 166
10.3 EUROPE 167
10.3.1 MACROECONOMIC OUTLOOK 167
10.3.2 GERMANY 170
10.3.2.1 Government initiatives enhancing domestic healthcare system to drive market 170
10.3.3 FRANCE 171
10.3.3.1 Escalating demand for early disease diagnosis to drive market 171
10.3.4 UK 173
10.3.4.1 Substantial rise in cancer and neurological disorders to drive market 173
10.3.5 ITALY 174
10.3.5.1 Elevated demand for cost-effective home care solutions to drive market 174
10.3.6 SPAIN 175
10.3.6.1 Surge in patients opting for enteral nutrition to drive market 175
10.3.7 REST OF EUROPE 177
10.4 ASIA PACIFIC 178
10.4.1 MACROECONOMIC OUTLOOK 178
10.4.2 CHINA 182
10.4.2.1 Growing investments in healthcare infrastructure development to drive market 182
10.4.3 JAPAN 184
10.4.3.1 Rapidly expanding geriatric population to drive market 184
10.4.4 INDIA 185
10.4.4.1 Large patient pool and increased per capita income to drive market 185
10.4.5 AUSTRALIA 187
10.4.5.1 Soaring volume of patients to drive market 187
10.4.6 SOUTH KOREA 188
10.4.6.1 Large number of private hospitals to drive market 188
10.4.7 REST OF ASIA PACIFIC 189
10.5 LATIN AMERICA 190
10.5.1 MACROECONOMIC OUTLOOK 190
10.5.2 BRAZIL 192
10.5.2.1 Improving healthcare facilities to drive market 192
10.5.3 MEXICO 194
10.5.3.1 Robust healthcare system with universal health coverage to drive growth 194
10.5.4 REST OF LATIN AMERICA 195
10.6 MIDDLE EAST & AFRICA 196
10.6.1 MACROECONOMIC OUTLOOK 197
10.6.2 GCC COUNTRIES 199
10.6.3 REST OF MIDDLE EAST & AFRICA 200
11 COMPETITIVE LANDSCAPE 201
11.1 INTRODUCTION 201
11.2 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 201
11.3 REVENUE ANALYSIS, 2020–2024 203
11.4 MARKET SHARE ANALYSIS, 2024 203
11.4.1 ENTERAL FEEDING TUBES MARKET SHARE 204
11.4.2 ENTERAL FEEDING PUMPS MARKET SHARE 204
11.4.3 ENTERAL SYRINGE PUMPS MARKET SHARE 205
11.4.4 CONSUMABLES & ACCESSORIES MARKET SHARE 205
11.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2024 208
11.5.1 STARS 208
11.5.2 EMERGING LEADERS 208
11.5.3 PERVASIVE PLAYERS 208
11.5.4 PARTICIPANTS 208
11.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2024 210
11.5.5.1 Company footprint 210
11.5.5.2 Region footprint 211
11.5.5.3 Product footprint 212
11.5.5.4 Application footprint 213
11.5.5.5 Age group footprint 214
11.5.5.6 End user footprint 215
11.6 COMPANY EVALUATION MATRIX: START-UPS/SMES, 2024 216
11.6.1 PROGRESSIVE COMPANIES 216
11.6.2 RESPONSIVE COMPANIES 216
11.6.3 DYNAMIC COMPANIES 216
11.6.4 STARTING BLOCKS 216
11.6.5 COMPETITIVE BENCHMARKING: START-UPS/SMES, 2024 218
11.6.5.1 List of start-ups/SMEs 218
11.6.5.2 Competitive benchmarking of start-ups/SMEs 219
11.7 COMPANY VALUATION AND FINANCIAL METRICS 220
11.8 PRODUCT/BRAND COMPARISON 221
11.9 COMPETITIVE SCENARIO 222
11.9.1 PRODUCT LAUNCHES AND APPROVALS 222
11.9.2 DEALS 223
12 COMPANY PROFILES 225
12.1 KEY PLAYERS 225
12.1.1 FRESENIUS SE & CO. KGAA 225
12.1.1.1 Business overview 225
12.1.1.2 Products offered 226
12.1.1.3 Recent developments 227
12.1.1.3.1 Expansions 227
12.1.1.3.2 Other developments 228
12.1.1.4 MnM view 228
12.1.1.4.1 Key strengths 228
12.1.1.4.2 Strategic choices 228
12.1.1.4.3 Weaknesses and competitive threats 228
12.1.2 CARDINAL HEALTH 229
12.1.2.1 Business overview 229
12.1.2.2 Products offered 230
12.1.2.3 Recent developments 231
12.1.2.3.1 Product launches and approvals 231
12.1.2.3.2 Deals 232
12.1.2.4 MnM view 232
12.1.2.4.1 Key strengths 232
12.1.2.4.2 Strategic choices 233
12.1.2.4.3 Weaknesses and competitive threats 233
12.1.3 NESTLÉ S.A. 234
12.1.3.1 Business overview 234
12.1.3.2 Products offered 235
12.1.3.3 MnM view 236
12.1.3.3.1 Key strengths 236
12.1.3.3.2 Strategic choices 237
12.1.3.3.3 Weaknesses and competitive threats 237
12.1.4 AVANOS MEDICAL, INC. 238
12.1.4.1 Business overview 238
12.1.4.2 Products offered 239
12.1.4.3 Recent developments 242
12.1.4.3.1 Product launches and approvals 242
12.1.4.3.2 Expansions 242
12.1.4.4 MnM view 242
12.1.4.4.1 Key strengths 242
12.1.4.4.2 Strategic choices 243
12.1.4.4.3 Weaknesses and competitive threats 243
12.1.5 DANONE S.A. 244
12.1.5.1 Business overview 244
12.1.5.2 Products offered 245
12.1.5.3 Recent developments 246
12.1.5.3.1 Deals 246
12.1.5.4 MnM view 247
12.1.5.4.1 Key strengths 247
12.1.5.4.2 Strategic choices 247
12.1.5.4.3 Weaknesses and competitive threats 247
12.1.6 BOSTON SCIENTIFIC CORPORATION 248
12.1.6.1 Business overview 248
12.1.6.2 Products offered 249
12.1.6.3 Recent developments 250
12.1.6.3.1 Deals 250
12.1.6.3.2 Expansions 251
12.1.7 BECTON, DICKINSON AND COMPANY 252
12.1.7.1 Business overview 252
12.1.7.2 Products offered 253
12.1.7.3 Recent developments 255
12.1.7.3.1 Product launches and approvals 255
12.1.8 B. BRAUN MELSUNGEN AG 256
12.1.8.1 Business overview 256
12.1.8.2 Products offered 257
12.1.9 CONMED CORPORATION 259
12.1.9.1 Business overview 259
12.1.9.2 Products offered 260
12.1.9.3 Recent developments 261
12.1.9.3.1 Deals 261
12.1.10 COOK MEDICAL 262
12.1.10.1 Business overview 262
12.1.10.2 Products offered 263
12.1.11 MOOG, INC. 265
12.1.11.1 Business overview 265
12.1.11.2 Products offered 266
12.1.12 BAXTER INTERNATIONAL INC. 268
12.1.12.1 Business overview 268
12.1.12.2 Products offered 269
12.1.12.3 Recent developments 270
12.1.12.3.1 Deals 270
12.1.13 VYGON 271
12.1.13.1 Business overview 271
12.1.13.2 Products offered 271
12.1.13.3 Recent developments 273
12.1.13.3.1 Deals 273
12.1.14 ENTERAL ACCESS TECHNOLOGIES LTD. 274
12.1.14.1 Business overview 274
12.1.14.2 Products offered 274
12.1.14.3 Recent developments 275
12.1.14.3.1 Other developments 275
12.1.15 FIDMI MEDICAL 276
12.1.15.1 Business overview 276
12.1.15.2 Products offered 276
12.1.15.3 Recent developments 277
12.1.15.3.1 Product launches and approvals 277
12.1.16 LIFEPUM MEDITECH 278
12.1.16.1 Business overview 278
12.1.16.2 Products offered 278
12.2 OTHER PLAYERS 279
12.2.1 APPLIED MEDICAL TECHNOLOGY, INC. 279
12.2.2 AMSINO INTERNATIONAL, INC. 280
12.2.3 OMEX MEDICAL TECHNOLOGY 282
12.2.4 DANUMED MEDIZINTECHNIK GMBH. 283
12.2.5 MEDLINE INDUSTRIES 284
12.2.6 FUJI SYSTEMS CORPORATION 285
12.2.7 KENTEC MEDICAL. 286
12.2.8 DYNAREX CORPORATION 287
12.2.9 VESCO MEDICAL, LLC 288
12.2.10 MEDELA AG 289
12.2.11 ALCOR SCIENTIFIC 290
12.2.12 ROMSONS 291
13 APPENDIX 293
13.1 DISCUSSION GUIDE 293
13.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 297
13.3 CUSTOMIZATION OPTIONS 299
13.4 RELATED REPORTS 300
13.5 AUTHOR DETAILS 301
LIST OF TABLES
TABLE 1 STANDARD CURRENCY CONVERSION RATES 30
TABLE 2 US: TOTAL NUMBER OF PRETERM BIRTHS, 2015–2021 55
TABLE 3 DIABETIC POPULATION, BY REGION, 2021 VS. 2030 VS. 2045 56
TABLE 4 GLOBAL CANCER INCIDENCE, 2015–2040 57
TABLE 5 US: GERIATRIC POPULATION, 2022–2050 (MILLION) 57
TABLE 6 COMPLICATIONS ASSOCIATED WITH ENTERAL FEEDING DEVICES 59
TABLE 7 PORTER’S FIVE FORCES ANALYSIS 64
TABLE 8 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 9 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 67
TABLE 10 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 11 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 68
TABLE 12 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 69
TABLE 13 REIMBURSEMENT CODES FOR VARIOUS PROCEDURES 69
TABLE 14 AVERAGE SELLING PRICE TREND OF G-TUBES OFFERED BY KEY PLAYERS,
2022–2024 (USD) 79
TABLE 15 AVERAGE SELLING PRICE TREND OF J-TUBES OFFERED BY KEY PLAYERS,
2022–2024 (USD) 80
TABLE 16 AVERAGE SELLING PRICE TREND OF NUTRITION STRAWS OFFERED BY KEY PLAYERS, 2022–2024 (USD) 81
TABLE 17 AVERAGE SELLING PRICE TREND OF ENTERAL SYRINGES OFFERED BY KEY PLAYERS, 2022–2024 (USD) 82
TABLE 18 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY REGION, 2022–2024 (USD) 83
TABLE 19 PATENT ANALYSIS 86
TABLE 20 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 88
TABLE 21 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 89
TABLE 22 KEY CONFERENCES AND EVENTS, 2025–2026 89
TABLE 23 KEY REQUIREMENTS OF STAKEHOLDERS WHEN BUYING ENTERAL
FEEDING DEVICES 91
TABLE 24 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE (%) 92
TABLE 25 BUYING CRITERIA FOR TOP THREE END USERS (%) 93
TABLE 26 UNMET CUSTOMER NEEDS AND KEY PAIN POINTS 93
TABLE 27 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 96
TABLE 28 ENTERAL FEEDING TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 97
TABLE 29 ENTERAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 97
TABLE 30 NORTH AMERICA: ENTERAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 31 EUROPE: ENTERAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 32 ASIA PACIFIC: ENTERAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 98
TABLE 33 LATIN AMERICA: ENTERAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 99
TABLE 34 MIDDLE EAST & AFRICA: ENTERAL FEEDING TUBES MARKET, BY REGION,
2023–2030 (USD MILLION) 99
TABLE 35 ENTERAL FEEDING TUBES MARKET, BY END USER, 2023–2030 (USD MILLION) 99
TABLE 36 MAJOR BRANDS OF NASAL FEEDING TUBES AVAILABLE IN MARKET 100
TABLE 37 NASAL FEEDING TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 101
TABLE 38 NASAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 101
TABLE 39 NORTH AMERICA: NASAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 101
TABLE 40 EUROPE: NASAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 102
TABLE 41 ASIA PACIFIC: NASAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 102
TABLE 42 LATIN AMERICA: NASAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 103
TABLE 43 MIDDLE EAST & AFRICA: NASAL FEEDING TUBES MARKET, BY REGION,
2023–2030 (USD MILLION) 103
TABLE 44 ORAL FEEDING TUBES MARKET, BY TYPE, 2023–2030 (USD MILLION) 104
TABLE 45 ORAL FEEDING TUBES MARKET, BY REGION, 2023–2030 (USD MILLION) 104
TABLE 46 NORTH AMERICA: ORAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 104
TABLE 47 EUROPE: ORAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 48 ASIA PACIFIC: ORAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 105
TABLE 49 LATIN AMERICA: ORAL FEEDING TUBES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 106
TABLE 50 MIDDLE EAST & AFRICA: ORAL FEEDING TUBES MARKET, BY REGION,
2023–2030 (USD MILLION) 106
TABLE 51 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY TYPE,
2023–2030 (USD MILLION) 107
TABLE 52 GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY REGION,
2023–2030 (USD MILLION) 107
TABLE 53 NORTH AMERICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 54 EUROPE: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 108
TABLE 55 ASIA PACIFIC: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 56 LATIN AMERICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 109
TABLE 57 MIDDLE EAST & AFRICA: GASTRIC OR GASTROSTOMY TUBES (G-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 109
TABLE 58 JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY TYPE, 2023–2030 (USD MILLION) 110
TABLE 59 JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 111
TABLE 60 NORTH AMERICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 61 EUROPE: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 111
TABLE 62 ASIA PACIFIC: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 63 LATIN AMERICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 112
TABLE 64 MIDDLE EAST & AFRICA: JEJUNOSTOMY TUBES (J-TUBES) MARKET, BY REGION, 2023–2030 (USD MILLION) 112
TABLE 65 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY TYPE,
2023–2030 (USD MILLION) 114
TABLE 66 GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET, BY REGION,
2023–2030 (USD MILLION) 114
TABLE 67 NORTH AMERICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023–2030 (USD MILLION) 114
TABLE 68 EUROPE: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY,
2023–2030 (USD MILLION) 115
TABLE 69 ASIA PACIFIC: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES) MARKET,
BY COUNTRY, 2023–2030 (USD MILLION) 115
TABLE 70 LATIN AMERICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES), BY COUNTRY, 2023–2030 (USD MILLION) 116
TABLE 71 MIDDLE EAST & AFRICA: GASTROSTOMY-JEJUNOSTOMY TUBES (GJ-TUBES),
BY REGION, 2023–2030 (USD MILLION) 116
TABLE 72 MAJOR BRANDS OF ENTERAL FEEDING PUMPS AVAILABLE IN MARKET 117
TABLE 73 ENTERAL FEEDING PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 117
TABLE 74 NORTH AMERICA: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 75 EUROPE: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 118
TABLE 76 ASIA PACIFIC: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 77 LATIN AMERICA: ENTERAL FEEDING PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 119
TABLE 78 MIDDLE EAST & AFRICA: ENTERAL FEEDING PUMPS MARKET, BY REGION,
2023–2030 (USD MILLION) 119
TABLE 79 ENTERAL FEEDING PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 120
TABLE 80 ENTERAL SYRINGE PUMPS MARKET, BY REGION, 2023–2030 (USD MILLION) 121
TABLE 81 NORTH AMERICA: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY
2023–2030 (USD MILLION) 121
TABLE 82 EUROPE: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 121
TABLE 83 ASIA PACIFIC: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 84 LATIN AMERICA: ENTERAL SYRINGE PUMPS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 122
TABLE 85 MIDDLE EAST & AFRICA: ENTERAL SYRINGE PUMPS MARKET, BY REGION,
2023–2030 (USD MILLION) 122
TABLE 86 ENTERAL SYRINGE PUMPS MARKET, BY END USER, 2023–2030 (USD MILLION) 123
TABLE 87 MAJOR BRANDS OF CONSUMABLES AVAILABLE IN MARKET 123
TABLE 88 CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2023–2030 (USD MILLION) 124
TABLE 89 CONSUMABLES & ACCESSORIES MARKET, BY REGION,
2023–2030 (USD MILLION) 124
TABLE 90 NORTH AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 91 EUROPE: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 125
TABLE 92 ASIA PACIFIC: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 93 LATIN AMERICA: CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 126
TABLE 94 MIDDLE EAST & AFRICA: CONSUMABLES & ACCESSORIES MARKET, BY REGION, 2023–2030 (USD MILLION) 126
TABLE 95 CONSUMABLES & ACCESSORIES MARKET, BY END USER,
2023–2030 (USD MILLION) 127
TABLE 96 SYRINGES MARKET, BY REGION, 2023–2030 (USD MILLION) 127
TABLE 97 NORTH AMERICA: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 98 EUROPE: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 99 ASIA PACIFIC: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 128
TABLE 100 LATIN AMERICA: SYRINGES MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 129
TABLE 101 MIDDLE EAST & AFRICA: SYRINGES MARKET, BY REGION,
2023–2030 (USD MILLION) 129
TABLE 102 EXTENSION SETS MARKET, BY REGION, 2023–2030 (USD MILLION) 130
TABLE 103 NORTH AMERICA: EXTENSION SETS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 130
TABLE 104 EUROPE: EXTENSION SETS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 130
TABLE 105 ASIA PACIFIC: EXTENSION SETS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 106 LATIN AMERICA: EXTENSION SETS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 131
TABLE 107 MIDDLE EAST & AFRICA: EXTENSION SETS MARKET, BY REGION,
2023–2030 (USD MILLION) 131
TABLE 108 ADAPTERS MARKET, BY REGION, 2023–2030 (USD MILLION) 132
TABLE 109 NORTH AMERICA: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 132
TABLE 110 EUROPE: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 111 ASIA PACIFIC: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 133
TABLE 112 LATIN AMERICA: ADAPTERS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 134
TABLE 113 MIDDLE EAST & AFRICA: ADAPTERS MARKET, BY REGION,
2023–2030 (USD MILLION) 134
TABLE 114 NUTRITION STRAWS MARKET, BY REGION, 2023–2030 (USD MILLION) 135
TABLE 115 NORTH AMERICA: NUTRITION STRAWS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 135
TABLE 116 EUROPE: NUTRITION STRAWS MARKET, BY COUNTRY, 2023–2030 (USD MILLION) 135
TABLE 117 ASIA PACIFIC: NUTRITION STRAWS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 118 LATIN AMERICA: NUTRITION STRAWS MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 136
TABLE 119 MIDDLE EAST & AFRICA: NUTRITION STRAWS MARKET, BY REGION,
2023–2030 (USD MILLION) 136
TABLE 120 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP, 2023–2030 (USD MILLION) 138
TABLE 121 NEONATAL PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 139
TABLE 122 PEDIATRIC PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 140
TABLE 123 ADULT PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 141
TABLE 124 GERIATRIC PATIENTS: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 142
TABLE 125 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 144
TABLE 126 ONCOLOGY: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 145
TABLE 127 LIST OF DIGESTIVE SYSTEM-RELATED DISEASES/DISORDERS 146
TABLE 128 GASTROINTESTINAL DISORDERS: ENTERAL FEEDING DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 147
TABLE 129 NEUROLOGICAL DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 148
TABLE 130 NEW DIABETES CASES, BY COUNTRY, 2022 149
TABLE 131 TOP 10 COUNTRIES WITH HIGHEST PROPORTION OF PATIENTS WITH TYPE 1 DIABETES 150
TABLE 132 DIABETES: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 150
TABLE 133 METABOLIC DISORDERS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 151
TABLE 134 OTHER APPLICATIONS: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 152
TABLE 135 ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 154
TABLE 136 HOSPITALS & SURGICAL CENTERS: ENTERAL FEEDING DEVICES MARKET,
BY REGION, 2023–2030 (USD MILLION) 155
TABLE 137 HOME CARE: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 156
TABLE 138 AMBULATORY CARE SETTINGS: ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 157
TABLE 139 OTHER END USERS: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 158
TABLE 140 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2023–2030 (USD MILLION) 160
TABLE 141 NORTH AMERICA: MACROECONOMIC OUTLOOK 161
TABLE 142 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 162
TABLE 143 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 163
TABLE 144 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 163
TABLE 145 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 164
TABLE 146 US: KEY MACRO INDICATORS 165
TABLE 147 US: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 165
TABLE 148 CANADA: KEY MACRO INDICATORS 166
TABLE 149 CANADA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 167
TABLE 150 EUROPE: MACROECONOMIC OUTLOOK 168
TABLE 151 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 168
TABLE 152 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 169
TABLE 153 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 169
TABLE 154 EUROPE: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 170
TABLE 155 GERMANY: KEY MACRO INDICATORS 171
TABLE 156 GERMANY: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 171
TABLE 157 FRANCE: KEY MACRO INDICATORS 172
TABLE 158 FRANCE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 172
TABLE 159 UK: KEY MACRO INDICATORS 173
TABLE 160 UK: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 174
TABLE 161 ITALY: KEY MACRO INDICATORS 175
TABLE 162 ITALY: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 175
TABLE 163 SPAIN: KEY MACRO INDICATORS 176
TABLE 164 SPAIN: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 176
TABLE 165 REST OF EUROPE: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 177
TABLE 166 ASIA PACIFIC: MACROECONOMIC OUTLOOK 179
TABLE 167 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 181
TABLE 168 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 181
TABLE 169 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 182
TABLE 170 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 182
TABLE 171 CHINA: KEY MACRO INDICATORS 183
TABLE 172 CHINA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 184
TABLE 173 JAPAN: KEY MACRO INDICATORS 185
TABLE 174 JAPAN: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 185
TABLE 175 INDIA: KEY MACRO INDICATORS 186
TABLE 176 INDIA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 187
TABLE 177 AUSTRALIA: KEY MACRO INDICATORS 187
TABLE 178 AUSTRALIA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 188
TABLE 179 SOUTH KOREA: KEY MACRO INDICATORS 189
TABLE 180 SOUTH KOREA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 189
TABLE 181 REST OF ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 190
TABLE 182 LATIN AMERICA: MACROECONOMIC OUTLOOK 191
TABLE 183 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY COUNTRY,
2023–2030 (USD MILLION) 191
TABLE 184 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 191
TABLE 185 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2023–2030 (USD MILLION) 192
TABLE 186 LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY END USER,
2023–2030 (USD MILLION) 192
TABLE 187 BRAZIL: KEY MACRO INDICATORS 193
TABLE 188 BRAZIL: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 193
TABLE 189 MEXICO: KEY MACRO INDICATORS 194
TABLE 190 MEXICO: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 195
TABLE 191 REST OF LATIN AMERICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 196
TABLE 192 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY REGION,
2023–2030 (USD MILLION) 197
TABLE 193 MIDDLE EAST & AFRICA: MACROECONOMIC OUTLOOK 197
TABLE 194 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT, 2023–2030 (USD MILLION) 198
TABLE 195 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY APPLICATION, 2023–2030 (USD MILLION) 198
TABLE 196 MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET, BY END USER, 2023–2030 (USD MILLION) 199
TABLE 197 GCC COUNTRIES: ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2023–2030 (USD MILLION) 199
TABLE 198 REST OF MIDDLE EAST & AFRICA: ENTERAL FEEDING DEVICES MARKET,
BY PRODUCT, 2023–2030 (USD MILLION) 200
TABLE 199 KEY PLAYER STRATEGIES/RIGHT TO WIN, 2020–2024 201
TABLE 200 ENTERAL FEEDING DEVICES MARKET: DEGREE OF COMPETITION 206
TABLE 201 REGION FOOTPRINT 211
TABLE 202 PRODUCT FOOTPRINT 212
TABLE 203 APPLICATION FOOTPRINT 213
TABLE 204 AGE GROUP FOOTPRINT 214
TABLE 205 END USER FOOTPRINT 215
TABLE 206 LIST OF START-UPS/SMES 218
TABLE 207 COMPETITIVE BENCHMARKING OF START-UPS/SMES 219
TABLE 208 ENTERAL FEEDING DEVICES MARKET: PRODUCT LAUNCHES AND APPROVALS, JANUARY 2021–APRIL 2025 222
TABLE 209 ENTERAL FEEDING DEVICES MARKET: DEALS, JANUARY 2021–APRIL 2025 223
TABLE 210 FRESENIUS SE & CO. KGAA: COMPANY OVERVIEW 225
TABLE 211 FRESENIUS SE & CO. KGAA: PRODUCTS OFFERED 226
TABLE 212 FRESENIUS SE & CO. KGAA: EXPANSIONS 227
TABLE 213 FRESENIUS SE & CO. KGAA: OTHER DEVELOPMENTS 228
TABLE 214 CARDINAL HEALTH: COMPANY OVERVIEW 229
TABLE 215 CARDINAL HEALTH: PRODUCTS OFFERED 230
TABLE 216 CARDINAL HEALTH: PRODUCT LAUNCHES AND APPROVALS 231
TABLE 217 CARDINAL HEALTH: DEALS 232
TABLE 218 NESTLÉ S.A.: COMPANY OVERVIEW 234
TABLE 219 NESTLÉ S.A.: PRODUCTS OFFERED 235
TABLE 220 AVANOS MEDICAL, INC.: COMPANY OVERVIEW 238
TABLE 221 AVANOS MEDICAL, INC.: PRODUCTS OFFERED 239
TABLE 222 AVANOS MEDICAL, INC.: PRODUCT LAUNCHES AND APPROVALS 242
TABLE 223 AVANOS MEDICAL, INC.: EXPANSIONS 242
TABLE 224 DANONE S.A.: COMPANY OVERVIEW 244
TABLE 225 DANONE S.A.: PRODUCTS OFFERED 245
TABLE 226 DANONE S.A.: DEALS 246
TABLE 227 BOSTON SCIENTIFIC CORPORATION: COMPANY OVERVIEW 248
TABLE 228 BOSTON SCIENTIFIC CORPORATION: PRODUCTS OFFERED 249
TABLE 229 BOSTON SCIENTIFIC CORPORATION: DEALS 250
TABLE 230 BOSTON SCIENTIFIC CORPORATION: EXPANSIONS 251
TABLE 231 BECTON, DICKINSON AND COMPANY: COMPANY OVERVIEW 252
TABLE 232 BECTON, DICKINSON AND COMPANY: PRODUCTS OFFERED 253
TABLE 233 BECTON, DICKINSON AND COMPANY: PRODUCT LAUNCHES AND APPROVALS 255
TABLE 234 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 256
TABLE 235 B. BRAUN MELSUNGEN AG: PRODUCTS OFFERED 257
TABLE 236 CONMED CORPORATION: COMPANY OVERVIEW 259
TABLE 237 CONMED CORPORATION: PRODUCTS OFFERED 260
TABLE 238 CONMED CORPORATION: DEALS 261
TABLE 239 COOK MEDICAL: COMPANY OVERVIEW 262
TABLE 240 COOK MEDICAL: PRODUCTS OFFERED 263
TABLE 241 MOOG, INC.: COMPANY OVERVIEW 265
TABLE 242 MOOG, INC.: PRODUCTS OFFERED 266
TABLE 243 BAXTER INTERNATIONAL INC.: COMPANY OVERVIEW 268
TABLE 244 BAXTER INTERNATIONAL INC.: PRODUCTS OFFERED 269
TABLE 245 BAXTER INTERNATIONAL INC.: DEALS 270
TABLE 246 VYGON: COMPANY OVERVIEW 271
TABLE 247 VYGON: PRODUCTS OFFERED 271
TABLE 248 VYGON: DEALS 273
TABLE 249 ENTERAL ACCESS TECHNOLOGIES LTD.: COMPANY OVERVIEW 274
TABLE 250 ENTERAL ACCESS TECHNOLOGIES LTD.: PRODUCTS OFFERED 274
TABLE 251 ENTERAL ACCESS TECHNOLOGIES LTD.: OTHER DEVELOPMENTS 275
TABLE 252 FIDMI MEDICAL: COMPANY OVERVIEW 276
TABLE 253 FIDMI MEDICAL: PRODUCTS OFFERED 276
TABLE 254 FIDMI MEDICAL: PRODUCT LAUNCHES AND APPROVALS 277
TABLE 255 LIFEPUM MEDITECH: COMPANY OVERVIEW 278
TABLE 256 LIFEPUM MEDITECH: PRODUCTS OFFERED 278
TABLE 257 APPLIED MEDICAL TECHNOLOGY, INC.: COMPANY OVERVIEW 279
TABLE 258 AMSINO INTERNATIONAL, INC.: COMPANY OVERVIEW 280
TABLE 259 OMEX MEDICAL TECHNOLOGY: COMPANY OVERVIEW 282
TABLE 260 DANUMED MEDIZINTECHNIK GMBH: COMPANY OVERVIEW 283
TABLE 261 MEDLINE INDUSTRIES: COMPANY OVERVIEW 284
TABLE 262 FUJI SYSTEMS CORPORATION: COMPANY OVERVIEW 285
TABLE 263 KENTEC MEDICAL.: COMPANY OVERVIEW 286
TABLE 264 DYNAREX CORPORATION: COMPANY OVERVIEW 287
TABLE 265 VESCO MEDICAL, LLC: COMPANY OVERVIEW 288
TABLE 266 MEDELA AG: COMPANY OVERVIEW 289
TABLE 267 ALCOR SCIENTIFIC: COMPANY OVERVIEW 290
TABLE 268 ROMSONS: COMPANY OVERVIEW 291
LIST OF FIGURES
FIGURE 1 ENTERAL FEEDING DEVICES MARKET SEGMENTATION 28
FIGURE 2 RESEARCH DATA 32
FIGURE 3 RESEARCH DESIGN 33
FIGURE 4 INSIGHTS FROM INDUSTRY EXPERTS 37
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 38
FIGURE 6 MARKET SIZE ESTIMATION: COMPANY REVENUE ESTIMATION 39
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY 40
FIGURE 8 MARKET SIZE ESTIMATION: TOP-DOWN APPROACH 41
FIGURE 9 GROWTH PROJECTIONS ON REVENUE IMPACT OF KEY MACRO INDICATORS 43
FIGURE 10 DATA TRIANGULATION 44
FIGURE 11 ENTERAL FEEDING DEVICES MARKET, BY PRODUCT,
2025 VS. 2030 (USD MILLION) 46
FIGURE 12 ENTERAL FEEDING DEVICES MARKET, BY APPLICATION,
2025 VS. 2030 (USD MILLION) 47
FIGURE 13 ENTERAL FEEDING DEVICES MARKET, BY AGE GROUP,
2025 VS. 2030 (USD MILLION) 47
FIGURE 14 ENTERAL FEEDING DEVICES MARKET, BY END USER,
2025 VS. 2030 (USD MILLION) 48
FIGURE 15 ENTERAL FEEDING DEVICES MARKET, BY REGION, 2025–2030 49
FIGURE 16 RISING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET 50
FIGURE 17 ASIA PACIFIC TO BE FASTEST-GROWING MARKET FOR ENTERAL FEEDING DEVICES DURING FORECAST PERIOD 51
FIGURE 18 HOSPITALS & SURGICAL CENTERS AND US WERE LARGEST SEGMENTS IN 2024 52
FIGURE 19 CHINA TO EXHIBIT FASTEST GROWTH DURING FORECAST PERIOD 53
FIGURE 20 ENTERAL FEEDING DEVICES MARKET DYNAMICS 54
FIGURE 21 ADOPTION OF ENTERAL FEEDING TUBES IN PATIENTS SUFFERING
FROM PRADER–WILLIE SYNDROME (2024) 56
FIGURE 22 PORTER’S FIVE FORCES ANALYSIS 64
FIGURE 23 ECOSYSTEM ANALYSIS 70
FIGURE 24 INVESTMENT AND FUNDING SCENARIO, 2019–2023 (USD MILLION) 70
FIGURE 25 NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 71
FIGURE 26 VALUE OF INVESTOR DEALS, BY KEY PLAYER, 2019–2023 (USD MILLION) 71
FIGURE 27 VALUE CHAIN ANALYSIS 75
FIGURE 28 SUPPLY CHAIN ANALYSIS 76
FIGURE 29 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING TUBES, BY TYPE,
2022–2024 (USD) 77
FIGURE 30 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY TYPE,
2022–2024 (USD) 78
FIGURE 31 AVERAGE SELLING PRICE TREND OF G-TUBES OFFERED BY KEY PLAYERS,
2022–2024 (USD) 79
FIGURE 32 AVERAGE SELLING PRICE TREND OF J-TUBES OFFERED BY KEY PLAYERS,
2022–2024 (USD) 80
FIGURE 33 AVERAGE SELLING PRICE TREND OF NUTRITION STRAWS OFFERED BY KEY PLAYERS, 2022–2024 (USD) 81
FIGURE 34 AVERAGE SELLING PRICE TREND OF ENTERAL SYRINGES OFFERED
BY KEY PLAYERS, 2022–2024 (USD) 82
FIGURE 35 AVERAGE SELLING PRICE TREND OF ENTERAL FEEDING DEVICES, BY REGION, 2022–2024 (USD) 83
FIGURE 36 PATENT ANALYSIS 85
FIGURE 37 IMPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 87
FIGURE 38 EXPORT DATA FOR HS CODE 901839-COMPLIANT PRODUCTS, BY COUNTRY, 2020–2024 (USD THOUSAND) 88
FIGURE 39 TRENDS AND DISRUPTIONS IMPACTING CUSTOMER BUSINESS 90
FIGURE 40 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS, BY PRODUCT TYPE 91
FIGURE 41 KEY BUYING CRITERIA FOR TOP THREE END USERS 92
FIGURE 42 AGE-STANDARDIZED RATE OF CANCER, BY REGION, 2022 145
FIGURE 43 NORTH AMERICA: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 162
FIGURE 44 ASIA PACIFIC: ENTERAL FEEDING DEVICES MARKET SNAPSHOT 180
FIGURE 45 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2024 203
FIGURE 46 ENTERAL FEEDING TUBES MARKET SHARE ANALYSIS, 2024 204
FIGURE 47 ENTERAL FEEDING PUMPS MARKET SHARE ANALYSIS, 2024 204
FIGURE 48 ENTERAL SYRINGE PUMPS MARKET SHARE ANALYSIS, 2024 205
FIGURE 49 CONSUMABLES & ACCESSORIES MARKET SHARE ANALYSIS, 2024 205
FIGURE 50 COMPANY EVALUATION MATRIX (KEY PLAYERS), 2024 209
FIGURE 51 COMPANY FOOTPRINT 210
FIGURE 52 COMPANY EVALUATION MATRIX (START-UPS/SMES), 2024 217
FIGURE 53 EV/EBITDA OF KEY VENDORS 220
FIGURE 54 5-YEAR STOCK BETA OF KEY VENDORS 220
FIGURE 55 BRAND/PRODUCT COMPARATIVE ANALYSIS 221
FIGURE 56 FRESENIUS SE & CO. KGAA: COMPANY SNAPSHOT 226
FIGURE 57 CARDINAL HEALTH: COMPANY SNAPSHOT 230
FIGURE 58 NESTLÉ S.A.: COMPANY SNAPSHOT 235
FIGURE 59 AVANOS MEDICAL, INC.: COMPANY SNAPSHOT 239
FIGURE 60 DANONE S.A.: COMPANY SNAPSHOT 245
FIGURE 61 BOSTON SCIENTIFIC CORPORATION: COMPANY SNAPSHOT 249
FIGURE 62 BECTON, DICKINSON AND COMPANY: COMPANY SNAPSHOT 253
FIGURE 63 B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT 257
FIGURE 64 CONMED CORPORATION: COMPANY SNAPSHOT 260
FIGURE 65 COOK MEDICAL: COMPANY SNAPSHOT 263
FIGURE 66 MOOG, INC.: COMPANY SNAPSHOT 266
FIGURE 67 BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT 269
MarketsandMarkets（マーケッツアンドマーケッツ）は世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。広範な市場を対象にした市場調査レポートを出版しています。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD8,150 | お問合せください | お問合せください | お問合せください |
ライセンスタイプ4
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- 自動車用アラミド繊維市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- ポリヒドロキシアルカノエート (PHA) 市場規模、シェア、動向、2030年までの世界予測 2025-12-15
- 複合輸送市場規模、シェア、動向、2032年までの世界予測 2025-12-12
- 有機酸市場規模、シェア、動向、2030年までの世界予測 2025-12-11
- ハイブリッドボンディング市場規模、シェア、動向、2032年までの世界予測 2025-12-11